Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

523.500
+0.5000.10%
Volume:498.71K
Turnover:259.87M
Market Cap:125.12B
PE:-270.80
High:543.000
Open:543.000
Low:511.500
Close:523.000
52wk High:581.000
52wk Low:339.600
Shares:239.00M
HK Float Shares:177.00M
Volume Ratio:0.66
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.933
ROE:2.92%
ROA:0.03%
PB:20.09
PE(LYR):-270.80
PS:51.41

Loading ...

SKB BIO (06990) Delivers on Both Performance and Innovation, Marking Its Biopharma Ascent

Stock News
·
Aug 17

China's Sichuan Kelun-Biotech Swings to Profit in H1 on New Product Approvals

Reuters
·
Aug 17

Sichuan Kelun-Biotech Biopharmaceutical Posts HY Net Income Attributable of RMB 388 MLN

Reuters
·
Aug 17

Press Release: Kelun-Biotech Announces 2026 Interim Results

Dow Jones
·
Aug 17

Sichuan Kelun-Biotech H1 Revenue RMB 978.3 Million

THOMSON REUTERS
·
Aug 17

Sichuan Kelun-Biotech H1 Net Income Attributable RMB 388 Million

THOMSON REUTERS
·
Aug 17

Kelun-Biotech Returns to Profit with FY26 H1 Net Income RMB 388.01 Million; Revenue Rises 2.9% to RMB 978.34 Million

Reuters
·
Aug 17

Movement Alert|SKB BIO Rises 3.15% in Regular Trading, Dual-Payload ADC Drug SKB565 Approved for Clinical Trials Ahead of Interim Results Review

Market Focus
·
Aug 07

Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds?

Simply Wall St.
·
Aug 06

Global AI Competition Heats Up, Commodity Stocks Rally in Hong Kong Markets

Stock News
·
Aug 06

Hong Kong Stock Moves: SKB BIO Surges Over 4% Before Noon as New Dual-Load ADC Drug Gets Clinical Trial Approval

Stock News
·
Aug 06

Movement Alert|SKB BIO Rises 3.4% in Regular Trading, Interim Results Review Approaching Amid Pipeline Catalysts

Market Focus
·
Aug 06

SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast

Bulletin Express
·
Aug 05

Kelun-Biotech Schedules Webcast Conference Call on Interim Results

Reuters
·
Aug 05

SKB BIO commits RMB 400.00 million to third BOC structured deposit, lifting total holdings to RMB 1.10 billion

Bulletin Express
·
Aug 04

SKB BIO Invests 400 Million Yuan in Bank of China Structured Deposits

Stock News
·
Aug 04

Sichuan Kelun-Biotech Biopharmaceutical Subscribes to BOC Structured Deposit III for Rmb400 MLN

Reuters
·
Aug 04

Sichuan Kelun-Biotech Biopharmaceutical Co - Subscribes to BOC Structured Deposit Iii for Rmb400 Mln on August 4, 2026

THOMSON REUTERS
·
Aug 04

Movement Alert|SKB BIO Declines 3.35% in Regular Trading, Commercial Bribery Allegations Continue to Weigh on Shares as Strict New Pharma Regulations Take Effect

Market Focus
·
Aug 03

Sichuan Kelun Biotech (SEHK:6990) Wins Priority Review For Sixth Sac TMT Indication

Simply Wall St.
·
Aug 01